ResearcherHeidelberg UniversityNo recent work listed
Alexandr V. Bazhin
Matched on ORCID iD 0000-0001-5994-4100; OpenAlex author ID A5028295345. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper
Papers 4
- Differential MicroRNA Expression Profiles as Potential Biomarkers for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1134/s0006297919050122↗
- The novel mitochondria-targeted antioxidant SkQ1 modulates angiogenesis and inflammatory micromilieu in a murine orthotopic model of pancreatic cancer. Co-author DOI 10.1002/ijc.30054↗
- Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells. Last author DOI 10.1080/2162402x.2014.998519↗
- Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer. Last author DOI 10.1002/ijc.27990↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Svetlana Karakhanova · 3 shared papers, 2013–2016 · strength 0.15
- Paper The novel mitochondria-targeted antioxidant SkQ1 modulates angiogenesis and inflammatory micromilieu in a murine orthot… DOI 10.1002/ijc.30054↗
- Paper Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppre… DOI 10.1080/2162402x.2014.998519↗
- Paper Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic can… DOI 10.1002/ijc.27990↗
- Jens Werner · 3 shared papers, 2013–2016 · strength 0.15
- Paper The novel mitochondria-targeted antioxidant SkQ1 modulates angiogenesis and inflammatory micromilieu in a murine orthot… DOI 10.1002/ijc.30054↗
- Paper Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppre… DOI 10.1080/2162402x.2014.998519↗
- Paper Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic can… DOI 10.1002/ijc.27990↗
- Ying Zhu · 1 shared paper, 2019 · strength 0.09
- Xiangqian Guo · 1 shared paper, 2019 · strength 0.09
- Ivan Shevchenko · 2 shared papers, 2013–2015 · strength 0.08
- Paper Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppre… DOI 10.1080/2162402x.2014.998519↗
- Paper Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic can… DOI 10.1002/ijc.27990↗
- Jan Goesta D’Haese · 1 shared paper, 2016 · strength 0.07
- Sabine Soltek · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.